Replacement, reduction, and refinement of animal experiments in anticancer drug development: the contribution of 3D in vitro cancer models in the drug efficacy …
In the last decades three-dimensional (3D) in vitro cancer models have been proposed as a
bridge between bidimensional (2D) cell cultures and in vivo animal models, the gold …
bridge between bidimensional (2D) cell cultures and in vivo animal models, the gold …
Fibroblasts in pancreatic cancer: molecular and clinical perspectives
Pancreatic stellate cells (PSCs) and cancer-associated fibroblasts (CAFs) are highly
abundant cells in the pancreatic tumor microenvironment (TME) that modulate desmoplasia …
abundant cells in the pancreatic tumor microenvironment (TME) that modulate desmoplasia …
Cancer Models on Chip: Paving the Way to Large‐Scale Trial Applications
Cancer kills millions of individuals every year all over the world (Global Cancer
Observatory). The physiological and biomechanical processes underlying the tumor are still …
Observatory). The physiological and biomechanical processes underlying the tumor are still …
The effect of 1, 2, 4-triazole-3-thiol derivatives bearing hydrazone moiety on cancer cell migration and growth of melanoma, breast, and pancreatic cancer spheroids
A Šermukšnytė, K Kantminienė, I Jonuškienė… - Pharmaceuticals, 2022 - mdpi.com
4-Phenyl-3-[2-(phenylamino) ethyl]-1 H-1, 2, 4-triazole-5 (4 H)-thione was used as a starting
compound for the synthesis of the corresponding 1, 2, 4-triazol-3-ylthioacetohydrazide …
compound for the synthesis of the corresponding 1, 2, 4-triazol-3-ylthioacetohydrazide …
3D bioprinting complex models of cancer
R Sharma, MR Perez, VA da Silva, J Thomsen… - Biomaterials …, 2023 - pubs.rsc.org
Cancer is characterized by the uncontrolled division of cells, resulting in the formation of
tumors. The tumor microenvironment (TME) consists of a variety of cell types present within a …
tumors. The tumor microenvironment (TME) consists of a variety of cell types present within a …
Exploring the impact of nanoparticle stealth coatings in cancer models: from PEGylation to cell membrane-coating nanotechnology
P Graván, J Peña-Martín, JL de Andrés… - … Applied Materials & …, 2023 - ACS Publications
Nanotechnological platforms offer advantages over conventional therapeutic and diagnostic
modalities. However, the efficient biointerfacing of nanomaterials for biomedical applications …
modalities. However, the efficient biointerfacing of nanomaterials for biomedical applications …
Stimuli‐responsive multifunctional nanomedicine for enhanced glioblastoma chemotherapy augments multistage blood‐to‐brain trafficking and tumor targeting
Minimal therapeutic advances have been achieved over the past two decades for
glioblastoma (GBM), which remains an unmet clinical need. Here, hypothesis‐driven stimuli …
glioblastoma (GBM), which remains an unmet clinical need. Here, hypothesis‐driven stimuli …
Biomaterials for drug delivery and human applications
P Trucillo - Materials, 2024 - mdpi.com
Biomaterials embody a groundbreaking paradigm shift in the field of drug delivery and
human applications. Their versatility and adaptability have not only enriched therapeutic …
human applications. Their versatility and adaptability have not only enriched therapeutic …
[HTML][HTML] Unraveling the mystery of efficacy in Chinese medicine formula: new approaches and technologies for research on pharmacodynamic substances
Y Li, Z Lin, Y Wang, S Ju, H Wu, H Jin, S Ma… - Arabian Journal of …, 2022 - Elsevier
Traditional Chinese medicine (TCM) is the key to unlock treasures of Chinese civilization.
TCM and its compound play a beneficial role in medical activities to cure diseases …
TCM and its compound play a beneficial role in medical activities to cure diseases …
Advances in screening hyperthermic nanomedicines in 3D tumor models
Hyperthermic nanomedicines are particularly relevant for tackling human cancer, providing
a valuable alternative to conventional therapeutics. The early-stage preclinical performance …
a valuable alternative to conventional therapeutics. The early-stage preclinical performance …